Harvest Fund Management Co. Ltd Buys 17,869 Shares of Doximity, Inc. (NASDAQ:DOCS)

Harvest Fund Management Co. Ltd grew its stake in Doximity, Inc. (NASDAQ:DOCS) by 198.1% in the 4th quarter, Holdings Channel.com reports. The fund owned 26,889 shares of the company’s stock after purchasing an additional 17,869 shares during the quarter. Harvest Fund Management Co. Ltd’s holdings in Doximity were worth $1,435,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Shaker Investments LLC OH bought a new position in shares of Doximity in the 4th quarter valued at about $559,000. Penserra Capital Management LLC bought a new position in shares of Doximity in the 3rd quarter valued at about $2,384,000. Principal Financial Group Inc. lifted its stake in Doximity by 1.5% in the 4th quarter. Principal Financial Group Inc. now owns 293,974 shares of the company’s stock valued at $15,695,000 after purchasing an additional 4,282 shares during the last quarter. Newbridge Financial Services Group Inc. acquired a new stake in Doximity in the 4th quarter valued at about $362,000. Finally, Stratos Wealth Partners LTD. acquired a new stake in Doximity in the 4th quarter valued at about $203,000. Institutional investors own 87.19% of the company’s stock.

Doximity Trading Up 2.2 %

Shares of DOCS stock opened at $62.68 on Thursday. The stock has a market cap of $11.70 billion, a P/E ratio of 62.68, a price-to-earnings-growth ratio of 4.10 and a beta of 1.34. The stock has a 50 day simple moving average of $64.04 and a 200 day simple moving average of $53.14. Doximity, Inc. has a 1 year low of $22.96 and a 1 year high of $85.21.

Insider Activity at Doximity

In related news, Director Timothy S. Cabral sold 20,000 shares of the business’s stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the sale, the director now directly owns 6,360 shares in the company, valued at approximately $366,463.20. The trade was a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. 37.40% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on DOCS. Leerink Partnrs upgraded shares of Doximity from a “hold” rating to a “strong-buy” rating in a research note on Friday, February 7th. Raymond James reiterated an “outperform” rating and issued a $83.00 target price (up from $65.00) on shares of Doximity in a research note on Friday, February 7th. KeyCorp cut their target price on shares of Doximity from $70.00 to $65.00 and set an “overweight” rating for the company in a research note on Wednesday, January 8th. Mizuho raised their target price on shares of Doximity from $55.00 to $65.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. Finally, Bank of America raised their target price on shares of Doximity from $54.00 to $57.00 and gave the company a “neutral” rating in a research note on Monday, January 6th. Eleven research analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $64.22.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.